Christopher A Johnson

3PUBLICATIONS
16CO-AUTHORS
Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 12, 2020
Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity.

Jinming Yang, Chi Yan, Anna E Vilgelm

|Aug 16, 2019
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21.

Anna E Vilgelm, Nabil Saleh, Rebecca Shattuck-Brandt

Pageof 1